Cryospray is a medical technique that delivers a controlled jet of extremely cold liquid nitrogen (or, in newer variants, solid nitrogen particles) directly onto diseased tissue, freezing and destroying it. The approach has gained traction across several specialties over the past two decades, from treating precancerous changes in the esophagus to clearing mucus-clogged airways in chronic lung disease and shrinking skin lesions. What makes cryospray distinct from older cryotherapy probes is the spray delivery itself, which allows clinicians to cover irregular tissue surfaces without pressing a metal tip against them, and the way frozen tissue tends to heal with less scarring and less pain than competing heat-based treatments.
How Cryospray Destroys Tissue
When liquid nitrogen hits living tissue, the surface temperature drops rapidly. The cold front moves inward, and at cooling rates roughly in the range of 50 to 200 °C per minute, ice crystals form inside cells rather than in the spaces between them.1Medical Engineering & Physics. Characterization of performance of multihole nozzle in cryospray That intracellular ice is the key to cell death. Ice crystals puncture membranes, disrupt internal structures, and when the tissue thaws, the damaged cells rupture. Researchers have modeled these “intracellular ice formation zones” in skin cancers treated with liquid nitrogen spray, mapping out exactly how deep the lethal freezing extends based on temperature and cooling speed.2International Journal of Spray and Combustion Dynamics. Numerical Prediction of the Intracellular ICE Formation Zone during Cryosurgery on a Nodular Basal Cell Carcinoma Using Liquid Nitrogen Spray
Beyond the direct freeze-kill, the cold also damages the tiny blood vessels feeding the treated area. Without blood supply, any cells that survived the initial freeze die over the following hours and days. The body then clears the dead tissue and regenerates new, healthier epithelium in its place. This two-phase destruction, immediate ice damage followed by vascular shutdown, is why cryospray can eliminate tissue to a meaningful depth even though the nitrogen itself contacts only the surface.
An emerging refinement uses micro-solid nitrogen particles instead of liquid droplets. Solid nitrogen at its triple point has roughly 15 percent higher thermal diffusivity than liquid nitrogen, and its latent heat when it jumps from solid directly to gas is about 26 percent greater than the latent heat of ordinary liquid-to-vapor boiling.3International Journal of Heat and Mass Transfer. The cooling performance of the micro-solid nitrogen spray technique on the cryopreservation vitrification process: A qualitative study In plain terms, the solid particles can pull heat out of tissue faster and absorb more of it per unit of material. This technique is being explored mainly for laboratory cryopreservation so far, but the physics translate directly to medical cryospray, where faster, deeper cooling would mean more precise tissue destruction.
Barrett’s Esophagus and Precancerous GI Conditions
The biggest clinical story for cryospray right now is in gastroenterology, particularly for Barrett’s esophagus. Barrett’s is a condition in which the normal lining of the lower esophagus gets replaced by tissue that looks more like the intestinal lining, usually because of long-standing acid reflux. The changed tissue can progress through stages of increasingly abnormal cell growth (dysplasia) and, in a small fraction of cases, develop into esophageal cancer. Endoscopic cryospray gives gastroenterologists a way to ablate that abnormal lining during a routine scope procedure.
Data from the National Cryospray Registry, the largest prospective dataset on the technique, showed that spray cryotherapy eliminated dysplasia in about 91 percent of patients with low-grade dysplasia and 81 percent with high-grade dysplasia. Complete eradication of the Barrett’s tissue itself (not just the dysplasia) was achieved in roughly 61 to 65 percent of cases. Patients with shorter segments of Barrett’s fared even better: dysplasia was wiped out in 97 percent and the Barrett’s tissue itself in 77 percent.4Diseases of the Esophagus. Safety and efficacy of endoscopic spray cryotherapy for Barrett’s dysplasia: results of the National Cryospray Registry
A more recent multicenter registry tracked outcomes over a longer period. At three years, complete eradication of dysplasia reached 92 percent, and complete eradication of intestinal metaplasia (the Barrett’s tissue) reached 67 percent. Among patients who had never been treated with radiofrequency ablation beforehand, the three-year numbers were even stronger: 96 percent for dysplasia and 77 percent for complete tissue clearance.5PubMed. Liquid nitrogen spray cryotherapy for eradication of dysplastic Barrett’s esophagus: results from a multicenter prospective registry Those figures put cryospray in the same ballpark as radiofrequency ablation, which has been the dominant endoscopic treatment for Barrett’s dysplasia for over a decade.
Cryospray as a Rescue After Failed Radiofrequency Ablation
Not everyone responds to radiofrequency ablation. Some patients have persistent or recurrent dysplasia despite multiple RFA sessions. For this group, cryospray has become a credible salvage option. A systematic review and meta-analysis of studies on cryotherapy after failed RFA found that about three-quarters of patients achieved complete eradication of dysplasia, and about half achieved complete eradication of the Barrett’s tissue.6PubMed Central. Cryotherapy for persistent Barrett’s esophagus after radiofrequency ablation: a systematic review and meta-analysis Individual studies have reported similar ranges. One found that 72 percent of RFA-failure patients cleared their dysplasia with cryotherapy, and 50 percent cleared the Barrett’s tissue entirely.7PubMed. Feasibility of liquid nitrogen cryotherapy after failed radiofrequency ablation for Barrett’s esophagus Another concluded that salvage cryotherapy for refractory or recurrent dysplasia after RFA was both safe and effective.8PubMed. Salvage cryotherapy after failed radiofrequency ablation for Barrett’s esophagus-related dysplasia is safe and effective
The fact that cryospray works through a different mechanism than RFA helps explain why switching modalities can succeed when repeating RFA does not. RFA delivers heat via electrodes pressed against the tissue, which works well on flat, uniform surfaces but struggles with irregular or scarred areas left behind by prior treatment. Cryospray, by contrast, coats the surface as a gas-and-liquid mist that conforms to uneven terrain. This mechanical difference may be why it picks up cases that RFA misses.
Pain, Strictures, and How Cryospray Compares to Heat-Based Ablation
One of the practical advantages patients care most about is pain. A head-to-head comparison found that patients treated with liquid nitrogen cryospray reported pain scores of about 0.4 on a 10-point scale immediately after the procedure, compared with roughly 1.2 to 1.4 for patients treated with radiofrequency ablation. At 48 hours, cryospray patients still had lower scores (about 0.8 versus 1.7 to 1.8). The odds of experiencing pain after RFA were at least five times greater than after cryospray.9Journal of Clinical Gastroenterology. Liquid Nitrogen Spray Cryotherapy is Associated With Less Postprocedural Pain Than Radiofrequency Ablation in Barrett’s Esophagus These are not dramatic pain levels for either group, but the difference matters for patients who need repeated sessions over months.
Stricture formation, the narrowing of the esophagus from scarring after treatment, is another concern. In one retrospective comparison, 21 percent of patients in the RFA group developed strictures.10Journal of Digestive Diseases and Hepatology. Retrospective Comparison between Radiofrequency Ablation Versus Cryotherapy for Treatment of Dysplastic Barrett’s Esophagus Another study looking at patients with persistent Barrett’s found stricture rates of 26 percent in the cryospray group and 35 percent in the RFA group, though that difference was not statistically significant given the sample size. When the researchers looked at which procedure actually caused each stricture, 71 percent were attributed to RFA, only 14 percent to cryospray, and the rest to prior tissue removal. That difference was statistically significant.11Diseases of the Esophagus. Spray cryotherapy versus continued radiofrequency ablation in persistent Barrett’s esophagus The pattern makes biological sense: cryospray tends to preserve the deeper structural layers of the esophageal wall while destroying the surface, whereas RFA can injure deeper tissue layers more uniformly.
Optical coherence tomography imaging has confirmed this. Researchers using 3D imaging to compare the two techniques found that RFA caused more visible surface damage, including sloughing mucosa and debris, while cryospray produced deeper but “spongier” edema-like changes measuring about 643 micrometers into the tissue, with less surface desquamation.12PubMed Central. Comparison of Tissue Architectural Changes between Radiofrequency Ablation and Cryospray Ablation in Barrett’s Esophagus Using Endoscopic Three-Dimensional Optical Coherence tomography In other words, cryospray’s freeze injury penetrates deeply but seems to leave the architecture more intact at the surface, which may explain the lower stricture rates and less pain.
Use in Esophageal Cancer With Complicating Conditions
Cryospray has also found a niche in situations where other ablation techniques are riskier. For patients with early-stage esophageal cancer who also have portal hypertension and esophageal varices (swollen, fragile blood vessels in the esophageal wall from liver disease), any treatment that applies direct mechanical pressure or heat to the tissue carries a meaningful bleeding risk. Two such patients were treated with liquid nitrogen cryosprays, and both had their cancers completely resolved after two treatment sessions, with no adverse events and no recurrence during up to two years of follow-up.13PubMed Central. Management of Early-Stage Esophageal Adenocarcinoma by Endoscopic Spray Cryotherapy in the Setting of Portal Hypertension With Varices This is a small case series, not a large trial, so the evidence is preliminary. But the logic is sound: because the spray does not require contact pressure and works through freezing rather than cautery, it may be gentler on fragile vascular tissue.
Airway Applications in Chronic Lung Disease
Outside the GI tract, one of the more promising frontiers for cryospray is in the airways of patients with chronic bronchitis, a component of COPD. Chronic bronchitis involves persistent inflammation of the bronchial tubes and an overgrowth of mucus-producing goblet cells in the airway lining. Patients cough constantly, produce excessive mucus, and gradually lose lung function. Current treatments manage symptoms but do not address the structural changes in the airway lining itself.
A metered cryospray system called RejuvenAir was developed specifically for this problem. The idea is to use a carefully dosed spray of liquid nitrogen to destroy the abnormal surface epithelium with its excess goblet cells, then allow the airway to regrow normal ciliated epithelium without the goblet cell overgrowth, reducing both chronic inflammation and mucus production.14PubMed Central. A prospective safety and feasibility study of metered cryospray for patients with chronic bronchitis in COPD Early feasibility studies have shown the approach is safe, and the concept of “resetting” the airway lining is genuinely different from anything else available for chronic bronchitis.
Animal research has provided more mechanistic detail. In a pilot study, spray cryotherapy reduced the number of mucus-positive cells in lung tissue, lowered levels of the mucin protein MUC5AC (one of the main components of airway mucus), and decreased acetylcholine levels in the fluid lining the airways. The researchers suggested that the acetylcholine-CHRM3 signaling pathway, which drives mucus secretion, may be one mechanism through which cryospray reduces excess mucus production.15PubMed. A pilot study of spray cryotherapy effects on airway secretions This is still early-stage science, but if the findings hold up in larger human trials, cryospray could become the first treatment that actually reverses the mucus-producing changes in chronic bronchitis rather than just suppressing symptoms.
Safety in Airway Procedures
Spraying liquid nitrogen inside an enclosed space like the airways raises an obvious concern: the nitrogen rapidly expands into gas, and if it cannot escape, it could over-pressurize the lung and cause a pneumothorax (collapsed lung). This risk has been studied carefully. Analytical modeling, laboratory testing, and animal studies have demonstrated that with appropriate passive venting, liquid nitrogen cryospray applications in the airway can be performed safely without pneumothorax risk.16Medical Engineering & Physics. N2 gas egress from patients’ airways during LN2 spray cryotherapy In practice, the endoscope channel and the natural space around it in the airway provide enough of a vent for the expanding nitrogen gas to escape back up through the mouth. Procedure protocols are designed with this physics in mind, and serious pressure-related complications have not been a meaningful problem in clinical use.
Treating Chronic Rhinitis
Cryotherapy applied to the nasal passages has been used to treat chronic rhinitis, the persistent nasal congestion, runny nose, and inflammation that affects millions of people. Most of the nasal cryotherapy literature uses probe-based devices rather than true spray delivery, but the underlying principle is the same: controlled freezing of the nasal mucosa and the overactive nerves supplying it. A systematic review of the evidence found significant improvement in validated symptom scores across all included studies, with only minor side effects like temporary pain, headache, and palate numbness. No major adverse events were identified.17PubMed Central. Cryoablation for the treatment of chronic rhinitis: a systematic review
An earlier qualitative review quantified the improvements. For obstructive symptoms, somewhere between 63 and 100 percent of patients reported improvement depending on the study. For runny nose specifically, 77 to 100 percent reported improvement. Patients with nonallergic rhinitis tended to respond better (67 to 97.5 percent improvement) than those with allergic rhinitis (63 to 80 percent), though both groups showed benefit.18PubMed. Cryotherapy for the Treatment of Chronic Rhinitis: A Qualitative Systematic Review The wide ranges reflect differences in technique, follow-up duration, and how “improvement” was measured, but the overall direction is consistent. For patients who have not responded to nasal sprays and antihistamines, cryotherapy offers a minimally invasive in-office option that can provide months or years of relief from a single treatment session.
Nozzle Design and Depth of Freeze
The engineering of the spray nozzle matters more than you might expect. The pattern, angle, and number of holes in the nozzle determine how evenly the cold is distributed across the target and how deep the lethal freezing zone reaches. Research on multihole nozzle designs found that the desired cooling rates for tissue destruction are achievable up to about 2 millimeters below the tissue surface and within a 10-millimeter radius from the center of the spray. The optimal safety margin around the target depends on the nozzle configuration: nozzles with a central hole performed best with a 1.5-millimeter margin, while those without a central hole achieved the best balance at 1 millimeter.19Medical Engineering & Physics. Characterization of performance of multihole nozzle in cryospray
These numbers might seem like fine engineering details, but they have direct clinical consequences. A nozzle that freezes too shallowly might leave deep dysplastic tissue alive. One that freezes too widely could damage healthy tissue unnecessarily. The drive toward more precisely engineered nozzles is part of a broader trend in cryospray toward dose-metering: controlling not just where the nitrogen lands but exactly how much cold is delivered to each square millimeter of tissue. The RejuvenAir system for lung disease, for instance, uses metered doses calibrated to destroy just the surface epithelium without injuring the deeper structural layers of the bronchial wall.
Dermatology and Skin Lesions
Cryotherapy has been a workhorse in dermatology long before endoscopic cryospray entered the picture. For actinic keratoses, the rough, scaly patches on sun-damaged skin that can progress to squamous cell carcinoma, cryotherapy is considered a standard first-line treatment for individual lesions.20PubMed Central. Cryotherapy for Actinic Keratosis: Basic Principles and Literature Review Most dermatologic cryotherapy uses a handheld canister that delivers a targeted stream of liquid nitrogen, which is essentially a miniaturized cryospray. The treatment takes seconds per lesion, requires no anesthesia, and heals over a week or two with minimal scarring.
Where dermatologic cryospray gets more interesting is in treating larger fields of sun-damaged skin. When dozens of actinic keratoses are scattered across a patient’s scalp or forearms, treating them one by one becomes tedious. Field-directed cryotherapy, which treats the entire affected area rather than individual spots, is an active area of development. The challenge is delivering a uniform freeze across a broad surface without under-treating some spots and over-treating others, and that is where the nozzle engineering and dose-metering advances from endoscopic cryospray could eventually cross-pollinate into dermatology.
Imaging Feedback During Cryospray Procedures
One limitation of any ablation technique is knowing, in real time, whether you have treated the right depth of tissue. You cannot see through the esophageal wall during an endoscopy. Optical coherence tomography, a type of light-based imaging that produces cross-sectional pictures of tissue layers at near-microscopic resolution, is being explored as a way to give clinicians immediate feedback during cryospray treatments. In a study comparing cryospray and RFA-treated tissue, 3D-OCT was able to distinguish the characteristic spongiform edema pattern of cryospray injury, measuring the depth of that injury at about 643 micrometers, from the more superficial sloughing pattern of RFA.21PubMed Central. Comparison of Tissue Architectural Changes between Radiofrequency Ablation and Cryospray Ablation in Barrett’s Esophagus Using Endoscopic Three-Dimensional Optical Coherence tomography If this kind of imaging becomes routine during cryospray procedures, clinicians could adjust treatment on the fly, adding another spray pass where the freeze looks too shallow or stopping where it looks adequate. That would be a significant step toward truly personalized cryoablation, where the dose is tailored to each patient’s anatomy and disease pattern rather than following a one-size-fits-all protocol.